140 related articles for article (PubMed ID: 18171331)
1. Standardization of nucleic acid amplification technique (NAT)-based assays for different genotypes of parvovirus B19: a meeting summary.
Baylis SA
Vox Sang; 2008 Jan; 94(1):74-80. PubMed ID: 18171331
[TBL] [Abstract][Full Text] [Related]
2. Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.
Baylis SA; Ma L; Padley DJ; Heath AB; Yu MW;
Vox Sang; 2012 Apr; 102(3):204-11. PubMed ID: 21988191
[TBL] [Abstract][Full Text] [Related]
3. Collaborative study for establishment of a European Pharmacopoeia Biological Reference Preparation (BRP) for B19 virus DNA testing of plasma pools by nucleic acid amplification technique.
Nübling CM; Daas A; Buchheit KH
Pharmeuropa Bio; 2004 Jan; 2003(2):27-34. PubMed ID: 14960261
[TBL] [Abstract][Full Text] [Related]
4. A proficiency testing study to evaluate laboratory performance for the detection of different genotypes of parvovirus B19.
Baylis SA; Buchheit KH
Vox Sang; 2009 Jul; 97(1):13-20. PubMed ID: 19416495
[TBL] [Abstract][Full Text] [Related]
5. Collaborative study to establish a replacement World Health Organization International Standard for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.
Baylis SA; Chudy M; Blümel J; Pisani G; Candotti D; José M; Heath AB
Vox Sang; 2010 Apr; 98(3 Pt 2):441-6. PubMed ID: 20003130
[TBL] [Abstract][Full Text] [Related]
6. Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes.
Jia J; Ma Y; Zhao X; Huangfu C; Zhong Y; Fang C; Fan R; Lv M; Zhang J
Virol J; 2016 Sep; 13(1):155. PubMed ID: 27639978
[TBL] [Abstract][Full Text] [Related]
7. A new quantitative PCR for human parvovirus B19 genotypes.
Toppinen M; Norja P; Aaltonen LM; Wessberg S; Hedman L; Söderlund-Venermo M; Hedman K
J Virol Methods; 2015 Jun; 218():40-5. PubMed ID: 25794796
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.
Koppelman MH; Rood IG; Fryer JF; Baylis SA; Cuypers HT
Vox Sang; 2007 Oct; 93(3):208-15. PubMed ID: 17845257
[TBL] [Abstract][Full Text] [Related]
9. Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA.
Koppelman MH; Cuijpers HT; Wessberg S; Valkeajärvi A; Pichl L; Schottstedt V; Saldanha J
Transfusion; 2012 Jul; 52(7):1498-508. PubMed ID: 22587637
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives.
Jia J; Ma Y; Zhao X; Guo Y; Huangfu C; Fang C; Fan R; Lv M; Yin H; Zhang J
Virol J; 2015 Oct; 12():162. PubMed ID: 26445095
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous detection and differentiation of human parvovirus B19 and human parvovirus 4 by an internally controlled multiplex quantitative real-time PCR.
Jia J; Zhong Y; Guo Y; Huangfu C; Zhao X; Fang C; Fan R; Ma Y; Zhang J
Mol Cell Probes; 2017 Dec; 36():50-57. PubMed ID: 28863892
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives.
Sun P; Jiang P; Liu Q; Zhang R; Wang Z; Cao H; Ye X; Ji S; Han J; Lu K; He X; Fan J; Cao D; Zhang Y; Yin Y; Chen Y; Zhao X; Ye S; Su N; Du X; Ma L; Li C
PeerJ; 2023; 11():e15698. PubMed ID: 37554334
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
14. Validation of new real-time polymerase chain reaction assays for detection of hepatitis A virus RNA and parvovirus B19 DNA.
Molenaar-de Backer MW; de Waal M; Sjerps MC; Koppelman MH
Transfusion; 2016 Feb; 56(2):440-8. PubMed ID: 26354230
[TBL] [Abstract][Full Text] [Related]
15. Standardization: a progress report.
Saldanha J
Biologicals; 1999 Dec; 27(4):285-9. PubMed ID: 10686054
[TBL] [Abstract][Full Text] [Related]
16. A significantly lower potency observed for the 3rd WHO International Standard for Parvovirus B19V DNA with the cobas TaqScreen DPX test.
Pisani G; Cristiano K; Fabi S; Simeoni M; Marino F; Gaggioli A
Vox Sang; 2016 Aug; 111(2):115-9. PubMed ID: 27149002
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.
Baylis SA; Shah N; Minor PD
J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers.
Ke L; He M; Li C; Liu Y; Gao L; Yao F; Li J; Bi X; Lv Y; Wang J; Hirsch ML; Li W
Transfusion; 2011 Sep; 51(9):1909-18. PubMed ID: 21382040
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.
Grabarczyk P; Kalińska A; Kara M; Wieczorek R; Ejduk A; Sulkowska E; Gołębiowska-Staroszczyk S; Matysiak M; Baylis SA; Brojer E
J Med Virol; 2011 Jan; 83(1):142-9. PubMed ID: 21108352
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous persistence of multiple genome variants of human parvovirus B19.
Schneider B; Höne A; Tolba RH; Fischer HP; Blümel J; Eis-Hübinger AM
J Gen Virol; 2008 Jan; 89(Pt 1):164-176. PubMed ID: 18089740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
